Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study JHAM 
There are over 450 new cases of non-Hodgkin's ly-mphoma and lymphoid leukaemia in the North West Region of England per year. in a population of 5.3 million.
The diagnosis and classification of these haematological malignancies has changed markedly over recent years (Ersboll et al.. 1985 : Wang. 1986 : Mead. 1987 ). Histological diagnosis is frequently difficult and classification may show wide variation when opinions of individual pathologists are compared with those of a lymphoma panel (Bird et al.. 1984 : Dick et al.. 1987a . Recent advances include the development of therapeutic regimens tailored to the cell type. stage of disease and presence of prognostic factors (Simon et al.. 1988: O'Reilly and Connors. 1992a) . It has been suggested that entrx into clinical trials and treatment at specialist centres may confer a therapeutic and survival advantage in patients with some forms of malignanc) (Stiller. 1989 (Stiller. . 1992 Youngson. 1984). One report suggested that the uneven distribution of experts in cancer care may lead to inadequate assessment and management (Mclllmurray. 1987) . Earlier work in the North Western Region has shown a wride variation in diagnostic cnrtenra and management procedures with inconsistent referral and survival patterns (Youngson, 1984) .
The aim of this study was to investigate the patterns of referral, treatment and survival in a group of patients with lymphoid malignancy ascertained from a specialist population-based registry with high levels of ascertainment and diagnostic accuracy.
Materials and methods
A specialist population-based registry for lymphoid leukaemia and non-Hodgkin's lymphoma was established for the North West Region in 1982. All cases of non-Hodgkin's lymphoma. the adult T-cell lymphomas ( (CLL) . prolymphocytic leukaemia (PLL) and hairycell leukaemia (HCL) were included. Cases were classified according to the Kiel classification (Gerard-Marchant et al.. 1974) and were grouped into low-grade. high-grade and unclassifiable for analysis. Cases in this studv were classified as CLL. rather than malignant lymphoma (ML) lymphocytic if the circulating lymphocyte count was greater than 10 000 cells mm-3. Cases referred to subsequently as CLL also include the variants PLL and HCL. The International Classification of Diseases for Oncology (ICDO) . WHO (1976) was used for coding.
Cases registered were aged 15 and over at diagnosis and resident within the North Western Regional Health Authority (NWRHA) boundary. Cases were ascertained from the North West Regional Cancer Registrv (NWRCR). histopathologists and haematologists throughout the region and from clinicians writh a particular responsibility for the management of this group of patients. The diagnoses of all cases were histologically confirmed and procedures established for a central review of diagnostic material. Slides were reviewed and additional immunostains were performed to establish lineage and clonality when indicated. The diagnosis on which the management was based was used in the analyses of treatment. irrespective of whether the classification changed subsequently.
Cases diagnosed between 1 January 1983 and 31 December 1986 and registered by 1 January 1989 were entered into the follow-up study. Demographic data and all information relating to the diagnosis and management were obtained from hospital records. Copies of death certificates wvere obtained from the Office of Population Censuses and Surveys via the NWRCR and the information was validated and enhanced with information from the hospital records.
The Ann Arbor staging classification was used for patients with ML (Carbone et al.. 1971 (Berkson and Gage. 1950 ) with an interval of 1 month, using the computer package BMDP1 L (BMDP, 1992) . The survival curves for the subgroups of each independent variable were compared using the log-rank test (Peto and Peto, 1972) .
Simultaneous effects of the variables on survival were explored using Cox's multivariate model (Cox, 1972) . The computer package BMDP2V (BMDP, 1992) and aged less than 70, fared better in clinical trials but the difference did not achieve statistical significance for lowgrade patients (P = 0.14). but was significant for high-grade patients (P = 0.04). 69  73  66  59  37  26  51  58  60  55  51  52  33  61  68  42  27  61  43  88  63  60  51  63  38  19  66  42  55  56  49  52  55  53  38  64  50  9  71  51  13  59  52  66  52  27  73 Tables VI and VII. CLL The overall median survival was 43 months, with a 2 year probability of survival of 61%. Social class 1 and 2 patients appeared to have a survival advantage compared to social class 3 to 5 patients (P = 0.018). The survival curves for the combination of the variables SOC and protocol are shown in Figure 3 . There were only ten patients who were treated at the SOC without a recognised protocol.
ALL The survival experience of 72 patients was analysed.
The overall 2 year survival was 34% with a median survival There was a strong interaction between age at diagnosis and whether a patient was treated according to protocol. The majority of younger patients were treated according to protocol and fared best and those over 65 years of age and not so treated fared worst.
As there was little difference in the survival patterns of leukaemia patients aged under 80 years, age was handled in the Cox analysis as a two category variable (<80, >80). Table VIII lists the most significant effect at each step of the Cox multivariate analysis. PS was the most significant variable related to survival, followed by grade. Several interaction effects were incorporated into the model. These suggested that PS2 and PS3 patients had a better survival if treated by a recognised protocol, patients aged 80 and over who were not treated according to a recognised protocol had a very poor prognosis, and an improved prognosis for females was most marked for PS3 patients.
Data
A specialist database was set up for the study of haematological malignancies to make ascertainment more timely and to ensure diagnostic accuracy. It was also felt that ascertainment by the NWRCR of low-grade conditions in the elderly, which may not have required hospital admission, may have been incomplete. limit the survival analysis of ML to those where pathology review had been carried out restricted the data set. particularly with regard to patients diagnosed dunrng 1983 and 1984. All the factors where cases without pathology review differed from those with review, that is older age, a lower probability of being treated according to a recognised protocol and a lower probability of referral to the SOC. would be likely to bias the results towards a better outcome. Differences in survival shown by this study are therefore likely to have been decreased by restricting the data set. Estimates of completeness have been made for the NWRCR (Benn et al., 1982; Nwene and Smith, 1982) and for the national cancer registration system (Swerdlow et al., 1993) and both found ascertainment levels for lymphomas of about 95%. Cross-validation checks with both the NWRCR and some laboratories showed that additional cases were included in the study and accuracy improved. However some cases of CLL diagnosed on a blood count had not been notified. The level of ascertainment of cases of ML and ALL, therefore is high and the study represents one of the few to attempt to capture a high proportion of cases of CLL.
The diagnosis of all cases was validated and a high proportion of diagnostic material was reviewed. (Bird et al., 1984) . The results of these studies are similar to our findings of 47% reclassification and 25% major revision.
In a two level pathology review, good concordance was found between the regional centre pathologist and the panel and for the most common lymphomas a second review by panel was considered unnecessary (Wolf et al., 1988) . Kim et al. (1982) found a discordance of 9% between the regional centre pathologists and a panel. ML cases in our study were reviewed by two regional centre pathologists.
Nearly 25% of the changes in diagnosis on review had clinical relevance. Without such histology review many ML patients may not receive the most appropriate therapy. Bartl et al. (1988) The problem of silent records is a major one for studies of 
